Evidence map›Paper›PMID 31694571›Full record

ArticleBMC cancer2019

Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.

Alexandra Kalmár, Zsófia Brigitta Nagy, Orsolya Galamb, István Csabai, András Bodor, Barnabás Wichmann, Gábor Valcz, Barbara Kinga Barták, Zsolt Tulassay, Peter Igaz and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Current issues in molecular biology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Alexandra Kalmár2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary. alexandra.kalmar@gmail.com.ORCID http://orcid.org/0000-0002-3824-1534
Zsófia Brigitta Nagy2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
Orsolya Galamb2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
István CsabaiDepartment of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.
András BodorDepartment of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.
Barnabás Wichmann2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
Gábor Valcz2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
Barbara Kinga Barták2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
Zsolt Tulassay2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
Peter Igaz2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
Béla Molnár2nd Department of Internal Medicine, Semmelweis University, Szentkirályi str. 46, Budapest, 1088, Hungary.
Semmelweis University · HUEötvös Loránd University · HU

Funding

Nemzeti Kutatási és Technológiai Hivatal KMR 12-1-2012-0216Nemzeti Kutatási és Technológiai Hivatal NKVP_16-1-2016-0004Novo Nordisk Foundation Interdisciplinary Synergy Programme Grant NNF15OC0016584The New National Excellence Program of the Ministry of Human Capacities, Hungary ÚNKP-17-4-III-SE-51The New National Excellence Program of the Ministry of Human Capacities, Hungary ÚNKP-17-4-I-SE-56
6 · The paper itself

Abstract

backgroundLong non-coding RNAs (lncRNAs) play a fundamental role in colorectal cancer (CRC) development, however, lncRNA expression profiles in CRC and its precancerous stages remain to be explored. We aimed to study whole genomic lncRNA expression patterns in colorectal adenoma-carcinoma transition and to analyze the underlying functional interactions of aberrantly expressed lncRNAs.

methodsLncRNA expression levels of colonic biopsy samples (20 CRCs, 20 adenomas (Ad), 20 healthy controls (N)) were analyzed with Human Transcriptome Array (HTA) 2.0. Expression of a subset of candidates was verified by qRT-PCR and in situ hybridization (ISH) analyses. Furthermore, in silico validation was performed on an independent HTA 2.0, on HGU133Plus 2.0 array data and on the TCGA COAD dataset. MiRNA targets of lncRNAs were predicted with miRCODE and lncBase v2 algorithms and miRNA expression was analyzed on miRNA3.0 Array data. MiRNA-mRNA target prediction was performed using miRWALK and c-Met protein levels were analyzed by immunohistochemistry. Comprehensive lncRNA-mRNA-miRNA co-expression pattern analysis was also performed.

resultsBased on our HTA results, a subset of literature-based CRC-associated lncRNAs showed remarkable expression changes already in precancerous colonic lesions. In both Ad vs. normal and CRC vs. normal comparisons 16 lncRNAs, including downregulated LINC02023, MEG8, AC092834.1, and upregulated CCAT1, CASC19 were identified showing differential expression during early carcinogenesis that persisted until CRC formation (FDR-adjusted p < 0.05). The intersection of CRC vs. N and CRC vs. Ad comparisons defines lncRNAs characteristic of malignancy in colonic tumors, where significant downregulation of LINC01752 and overexpression of UCA1 and PCAT1 were found. Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). In line with aberrant expression of certain lncRNAs in tumors, the expression of miRNA and mRNA targets showed systematic alterations. For example, UCA1 upregulation in CRC samples occurred in parallel with hsa-miR-1 downregulation, accompanied by c-Met target mRNA overexpression (p < 0.05).

conclusionThe defined lncRNA sets may have a regulatory role in the colorectal adenoma-carcinoma transition. A subset of CRC-associated lncRNAs showed significantly differential expression in precancerous samples, raising the possibility of developing adenoma-specific markers for early detection of colonic lesions.

Indexed as

Gene Expression Regulation, NeoplasticAdenomaAdultAgedCarcinomaColorectal NeoplasmsGene Expression ProfilingGene OntologyGene Regulatory NetworksHumansMiddle AgedModels, GeneticRNA, Long NoncodingYoung AdultRNA, Long NoncodingColorectal adenomaColorectal cancerHuman transcriptome Array 2.0ImmunohistochemistryIn situ hybridizationlncRNALong non-coding RNAMicroarrayqRT-PCRUCA1

Identifiers

PMID31694571
PMCPMC6836529
OpenAlexW2984562286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.